Thermal induced changes of rice straw phytolith in relation to arsenic release: A perspective of rice straw arsenic under open burning.

On-site open burning is a common practice for handling rice straw, but its negative impacts, e.g., biomass loss and air pollution, are largely debated worldwide. To address the negative effects of open burning, many efforts have been made to 'ignite' worldwide bans. However, these bans are likely based on a singular view in which some positive aspects of open burning are overlooked. In this study, we aimed to determine the thermal-induced changes of straw and straw arsenic (As) under open burning and heat-treatments (in the temperature range from 300 to 900 °C). It was found that silica phase in rice straw (so-called phytolith) can encapsulate As in its structure. Open burning or heat-treatment of straw resulted in a tighter association of As and phytolith, thereby reducing dissolution of As. We proposed an opinion that open burning causes air pollution, but it can increase the activity of phytolith in sequestrating As, enabling delayed As cycle in rice ecosystems. The combat of on-site open burning of rice straw to reduce air pollution will alter straw handling routines, thereby changing the cycle of straw phytolith and the route of straw As.

Colloidal interactions of micro-sized biochar and a kaolinitic soil clay.

Fine-sized biochars and clay minerals co-present in various circumstances, e.g., agricultural land and water treatment. Because both of these materials are scavengers for nutrients, agrochemicals and other toxicants, their dispersibility and transportability have received much attention. However, little is documented about their colloidal interactions and to what extent biochar particles can stimulate the dispersion of clay minerals. Here, the effect of engineered micro-sized biochar amendment on the surface charge (SC) and colloidal dynamics of the clay fraction of a kaolinite-rich soil was determined. The engineered biochars showed distinctive SC and colloidal properties depending on their pyrolysis conditions (e.g., oxygen level and temperature) and solution chemistry (i.e., pH and cation type). Two types of biochars prepared under non-biochar-oriented pyrolysis (open heating, 'O-biochar') and biochar-oriented pyrolysis (N2-supported heating, 'N2-biochar') showed contrasting effects on the colloidal dynamics of clay. The O-biochars provoked aggregation due to their higher content of soluble salts, which increased ionic strength and provided multivalent cations, inducing bridging between negatively charged colloids. In contrast, the N2 biochars low in soluble salts and rich in negatively charged burned organic matter compounds favoured the dispersion of clay. The adjustment of biochar production methods can therefore be highlighted as the way to customize biochar for specific uses or to reduce the risk of clay loss from soils in the short term. In the long term, when soluble salts are removed by leaching, it is likely that dispersion is facilitated and the risk for erosion increases.

Assessing and modelling vulnerability to dengue in the Mekong Delta of Vietnam by geospatial and time-series approaches.

Dengue fever has continuously been a disease burden in Vietnam during the last 20 years, particularly in the Mekong Delta region (MDR), which is one of the most vulnerable to climate change. Variations in temperature and precipitation are likely to alter the incidence and distribution of vector-borne diseases such as dengue. This study focuses on assessing dengue risk via the vulnerability concept, which is composed of exposure and susceptibility using a combined approach of mapping and modelling for the MDR of Vietnam during the period between 2001 and 2016. Multisource remote sensing data from Global Satellite Mapping of Precipitation (GSMaP) and Moderate Resolution Imaging Spectrophotometer (MODIS) was used for presenting climate and environment variables in mapping and modelling vulnerability. Monthly and yearly maps of vulnerability to dengue in the MDR, produced for 15-year period, aided analysis of the temporal and spatial patterns of vulnerability to dengue in the study region and were used for constructing time-series modelling of vulnerability for the following year. The results showed that there is a clear seasonal variation in the vulnerability due to variability of the climate factor and its strong dispersion across the study region, with higher vulnerability in the scattered areas of urban and mixed horticulture land and lower vulnerability in areas covered by forest and bare soil lands. The Pearson's correlation was applied to evaluate the association between dengue rates and vulnerability values aggregated at the provincial level. Reasonable linear association, with correlation coefficients of 0.41-0.63, was found in two-thirds of the provinces. The predicted vulnerabilities to dengue during 2016 were comparable with the estimated values and trends for most provinces of the MDR. Our demonstrated approach with integrated geospatial data seems to be a promising tool in supporting the public health sector in assessing potential space and time of a subsequent increase in vulnerability to dengue, particularly in the context of climate change.

Potential of electrolyzed water for disinfection of foot-and-mouth disease virus.

Acidic electrolyzed water (EW) (pH 2.6-5.8) and alkaline EW (pH 11.2-12.1) were examined as potential disinfectants against foot-and-mouth disease virus (FMDV). Using acidic EW with pH 2.6 and alkaline EW with pH >11.7, the viral titer decreased in vitro by > 4.0 log values, 2 min after the virus was mixed with EW at a 1:10 dilution. The strong virucidal effect of acidic EW (pH 2.6), but not that of alkaline EW (>11.7), seemed to depend on the chlorine level in the solution. Genetic analysis revealed that viral RNA was substantially reduced, especially by alkaline EW.

Pathogenicity of an H5N1 avian influenza virus isolated in Vietnam in 2012 and reliability of conjunctival samples for diagnosis of infection.

The continued spread of highly pathogenic avian influenza virus (HPAIV) subtype H5N1 among poultry in Vietnam poses a potential threat to animals and public health. To evaluate the pathogenicity of a 2012 H5N1 HPAIV isolate and to assess the utility of conjunctival swabs for viral detection and isolation in surveillance, an experimental infection with HPAIV subtype H5N1 was carried out in domestic ducks. Ducks were infected with 10(7.2) TCID50 of A/duck/Vietnam/QB1207/2012 (H5N1), which was isolated from a moribund domestic duck. In the infected ducks, clinical signs of disease, including neurological disorder, were observed. Ducks started to die at 3 days-post-infection (dpi), and the study mortality reached 67%. Viruses were recovered from oropharyngeal and conjunctival swabs until 7 dpi and from cloacal swabs until 4 dpi. In the ducks that died or were sacrificed on 3, 5, or 6 dpi, viruses were recovered from lung, brain, heart, pancreas and intestine, among which the highest virus titers were in the lung, brain or heart. Results of virus titration were confirmed by real-time RT-PCR. Genetic and phylogenetic analysis of the HA gene revealed that the isolate belongs to clade 2.3.2.1 similarly to the H5N1 viruses isolated in Vietnam in 2012. The present study demonstrated that this recent HPAI H5N1 virus of clade 2.3.2.1 could replicate efficiently in the systemic organs, including the brain, and cause severe disease with neurological symptoms in domestic ducks. Therefore, this HPAI H5N1 virus seems to retain the neurotrophic feature and has further developed properties of shedding virus from the oropharynx and conjunctiva in addition to the cloaca, potentially posing a higher risk of virus spread through cross-contact and/or environmental transmission. Continued surveillance and diagnostic programs using conjunctival swabs in the field would further verify the apparent reliability of conjunctival samples for the detection of AIV.

Emerging Therapeutic Options for the Management of COPD.

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.

Roflumilast: a novel treatment for chronic obstructive pulmonary disease.

OBJECTIVE: To evaluate the efficacy and safety of roflumilast, approved by the Food and Drug Administration in February 2011 as a treatment to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. DATA SOURCES: Literature was retrieved through MEDLINE (1977-December 2011), using the terms roflumilast and COPD. In addition, US government Web sites, including clinicaltrials.gov and fda.gov, were reviewed for pertinent information. Lastly, reference citations from publications identified were reviewed. STUDY SELECTION AND DATA EXTRACTION: All articles published in English identified from the data sources were evaluated. For the evaluation of clinical efficacy and safety, only Phase 3 studies were included. DATA SYNTHESIS: Limited treatment options are available for patients with moderate-to-severe COPD and repeated exacerbations. In 6 published Phase 3 trials to date, roflumilast 500 µg daily exhibited modest improvements in lung function, measured by pre- and postbronchodilator forced expiratory volume in 1 second, and reduced rates of moderate and severe exacerbations. Roflumilast was generally well tolerated, with diarrhea, nausea, and headache the most common adverse events seen in clinical trials, although it has also been associated with an increased risk of neuropsychiatric abnormalities and dose-limiting weight loss. The greatest benefit seen with roflumilast was among patients with moderate-to-severe COPD associated with chronic bronchitis along with a recent history of exacerbations. The benefits were demonstrated with monotherapy and in combination with long-acting ß(2)-agonists or anticholinergic agents. CONCLUSIONS: Despite its only modest benefits in improving lung function and reducing exacerbation rates, roflumilast serves as a safe and effective option in the treatment of COPD.